Vyome Holdings, Inc. (HIND)

2.25 +0.01 (+0.36%) USD  |  NASDAQ  |  Aug 25, 16:00
2.25 0.00 (0.00%) After-Hours: 17:37
More

Vyome Holdings Revenue Estimates for Current Quarter

Revenue Estimates for Current Quarter Chart

View Revenue Estimates for Current Quarter for HIND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Current Quarter Chart
Start Trial

Historical Revenue Estimates for Current Quarter Data

View and export this data back to 2025. Start Trial.
Date Value
May 19, 2026 --
March 25, 2026 --
November 18, 2025 --
Date Value
October 02, 2025 --
September 30, 2025 --

Revenue Estimates for Current Quarter Range, Past 5 Years

View Revenue Estimates for Current Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Current Quarter Benchmarks

View Revenue Estimates for Current Quarter Benchmarks
Start Trial
Cardiac Biotech Solutions, Inc. --
Anika Therapeutics, Inc. Upgrade
Enovis Corp. Upgrade
Edwards Lifesciences Corp. Upgrade
Perspective Therapeutics, Inc. Upgrade

Revenue Estimates for Current Quarter Related Metrics

Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade